کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2405398 | 1103033 | 2009 | 11 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
single radial haemolysisHaemagglutination-inhibitionAlPO4eCBsTIVSRHVLPHAIAdverse events following immunisationH5N1AEFITrivalent inactivated vaccineCHMPLAIVClinical trials - آزمایشات بالینیAl(OH)3 - آل (OH) 3Aluminium phosphate - آلومینیوم فسفاتInfluenza - آنفلوانزا Virus-like particle - ذره مانند ویروسReverse genetics - معکوس ژنتیکmicroneutralization - میکروسکوپ الکترونیAluminium hydroxide - هیدروکسید آلومینیومVaccine - واکسنLive-attenuated influenza vaccine - واکسن آنفلوانزا واکسن زندهpandemic - پاندمی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
On the 12-13 February 2009, the Initiative For Vaccine Research (IVR) of the World Health Organisation convened the 5th meeting on the 'Evaluation of pandemic influenza prototype vaccines in clinical trials' in Geneva. This was a follow-up meeting to the 4th meeting held on 14-15 February 2008 [Girard M, Palkonyay L, Kieny MP. Report of the 4th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials. Vaccine 2008;26:4975-7], and presentations were made by representatives from industry, academia, and governmental organisations. This year's meeting aimed to update the progress made during the past year on H5N1 and other prototype pandemic vaccines that have undergone clinical trials. A number of vaccine types were covered, including classical egg-derived inactivated vaccines, cell-derived inactivated vaccines, live-attenuated vaccines (LAIV) and vaccines developed using new technologies. The effects of different adjuvants and prime-boosting schedules were important topics, and further data were presented to show that children mount vigorous antibody responses to several H5N1 vaccines. Other subjects presented and discussed were standardisation, and regulatory issues concerning pandemic vaccines.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 27, Issue 31, 24 June 2009, Pages 4079-4089
Journal: Vaccine - Volume 27, Issue 31, 24 June 2009, Pages 4079-4089
نویسندگان
Frederick G. Hayden, Wendy A. Howard, Laszlo Palkonyay, Marie Paule Kieny,